Clinical Trial Update: Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 7 versus 14 days of antibiotic therapy for Pseudomonas aeruginosa bloodstream infection, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Bloodstream Infection

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Bloodstream Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING